Literature DB >> 10894818

G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia.

J Pihlajamäki1, L Karjalainen, P Karhapää, I Vauhkonen, M R Taskinen, S S Deeb, M Laakso.   

Abstract

Low activity of hepatic lipase (HL) has been associated with high levels of triglycerides and high density lipoproteins, but the association of the HL promoter variants with insulin sensitivity has not been investigated. Therefore, in this study, the relationship of the G-250A promoter variant of the HL gene to the rates of insulin-stimulated glucose uptake measured by the hyperinsulinemic euglycemic clamp was investigated in 110 control subjects (82 men and 28 women, aged 50.7+/-7.6 [mean+/-SD] years, body mass index 26. 1+/-3.6 kg/m(2)) and in 105 first-degree relatives (65 men and 40 women, aged 47.8+/-16.0 years, body mass index 26.9+/-5.3 kg/m(2)) of 34 families with familial combined hyperlipidemia (FCHL). The A-250 allele of the HL promoter was associated with low rates of insulin-stimulated whole-body nonoxidative glucose disposal in control subjects (41.1+/-12.7 micromol. kg(-1). min(-1) in subjects with the G-250G genotype, 36.9+/-13.1 micromol. kg(-1). min(-1) in subjects with the G-250A genotype, and 29.9+/-13.5 micromol. kg(-1). min(-1) in subjects with the A-250A genotype; P=0.012 adjusted for age and sex) and with low rates of insulin-stimulated whole-body glucose oxidation in FCHL family members (16.7+/-4.2 versus 15.0+/-4. 4 versus 14.1+/-4.4 micromol. kg(-1). min(-1), P=0.024). In addition, the A-250 allele was associated with high levels of fasting insulin (P=0.047), very low density lipoprotein cholesterol (P=0.007), and total (P=0.009) and very low density lipoprotein (P=0.005) triglycerides in control subjects and with high levels of low density lipoprotein triglycerides (P=0.001) in FCHL family members (n=340). We conclude that the G-250A promoter variant of the HL gene is associated with dyslipidemia and insulin resistance. Mechanisms via which this polymorphism could affect insulin sensitivity remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10894818     DOI: 10.1161/01.atv.20.7.1789

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  13 in total

Review 1.  The genetics of familial combined hyperlipidaemia.

Authors:  Martijn C G J Brouwers; Marleen M J van Greevenbroek; Coen D A Stehouwer; Jacqueline de Graaf; Anton F H Stalenhoef
Journal:  Nat Rev Endocrinol       Date:  2012-02-14       Impact factor: 43.330

2.  Upstream transcription factor 1 gene polymorphisms are associated with high antilipolytic insulin sensitivity and show gene-gene interactions.

Authors:  Konstantinos Kantartzis; Andreas Fritsche; Fausto Machicao; Michael Stumvoll; Jürgen Machann; Fritz Schick; Hans-Ulrich Häring; Norbert Stefan
Journal:  J Mol Med (Berl)       Date:  2006-09-26       Impact factor: 4.599

3.  Dietary fat modulation of hepatic lipase variant -514 C/T for lipids: a crossover randomized dietary intervention trial in Caribbean Hispanics.

Authors:  C E Smith; M I Van Rompay; J Mattei; J F Garcia; B Garcia-Bailo; A H Lichtenstein; K L Tucker; J M Ordovás
Journal:  Physiol Genomics       Date:  2017-09-22       Impact factor: 3.107

4.  Association of LIPC -250G>A polymorphism and several environmental factors with serum lipid levels in the Guangxi Bai Ku Yao and Han populations.

Authors:  Li Meng; Yin Ruixing; Li Yiyang; Long Xingjiang; Li Kela; Liu Wanying; Zhang Lin; Lin Weixiong; Yang Dezhai; Pan Shangling
Journal:  Lipids Health Dis       Date:  2010-03-11       Impact factor: 3.876

5.  WWOX gene is associated with HDL cholesterol and triglyceride levels.

Authors:  María E Sáez; Antonio González-Pérez; María T Martínez-Larrad; Javier Gayán; Luis M Real; Manuel Serrano-Ríos; Agustín Ruiz
Journal:  BMC Med Genet       Date:  2010-10-14       Impact factor: 2.103

6.  The rs2070895 (-250G/A) Single Nucleotide Polymorphism in Hepatic Lipase (HL) Gene and the Risk of Coronary Artery Disease in North Indian Population: A Case-Control Study.

Authors:  Pratima Verma; Dileep Kumar Verma; Rishi Sethi; Shraddha Singh; Akhilesh Krishna
Journal:  J Clin Diagn Res       Date:  2016-08-01

7.  Glucose increases hepatic lipase expression in HepG2 liver cells through upregulation of upstream stimulatory factors 1 and 2.

Authors:  D van Deursen; H Jansen; A J M Verhoeven
Journal:  Diabetologia       Date:  2008-08-30       Impact factor: 10.122

8.  Association between two common polymorphisms (single nucleotide polymorphism -250G/A and -514C/T) of the hepatic lipase gene and coronary artery disease in type 2 diabetic patients.

Authors:  Ghorban Mohammadzadeh; Mohammad-Ali Ghaffari; Mohammad Bazyar; Alireza Kheirollah
Journal:  Adv Biomed Res       Date:  2016-02-15

Review 9.  Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date.

Authors:  Antonio Gaddi; A F G Cicero; F O Odoo; A A Poli; R Paoletti
Journal:  Vasc Health Risk Manag       Date:  2007

10.  Gender specific effect of LIPC C-514T polymorphism on obesity and relationship with plasma lipid levels in Chinese children.

Authors:  Hao Wang; Dandan Zhang; Jie Ling; Wenhui Lu; Shuai Zhang; Yimin Zhu; Maode Lai
Journal:  J Cell Mol Med       Date:  2015-08-18       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.